Angiopoietin‐like protein 4 (ANGPTL4) is induced by high glucose in retinal pigment epithelial cells and exhibits potent angiogenic activity on retinal endothelial cells

Acta Ophthalmologica - Tập 91 Số 4 - 2013
Hirotaka Yokouchi1,2, Kohei Eto1, Wataru Nishimura1, Norio Takeda3, Yasushi Kaburagi1,4, Shuichi Yamamoto2, Kazuki Yasuda1
1Department of Metabolic Disorder, Diabetes Research Center, Research Institute, Tokyo, Japan
2Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan
3Department of Ophthalmology, Hospital, National Center for Global Health and Medicine, Tokyo, Japan
4Present address: Department of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Tóm tắt

Abstract.Purpose:  Hyperglycaemia has been identified as major risk factor for diabetic retinopathy (DR). It is widely accepted that the progression of DR is mainly due to a local imbalance of pro‐ versus anti‐angiogenic factors in the retina. In this study, we investigated whether retinal pigment epithelial (RPE) cells produced pro‐angiogenic factors under high glucose (HG) conditions in vitro.Methods:  Cultured human retinal endothelial (RE) cells were exposed to conditioned medium from retinal pigment epithelium cells (ARPE‐19) grown in HG medium and assessed for tube formation. Based on the expression profiles of ARPE‐19, we investigated whether ANGPTL4 was a major angiogenic factor released from ARPE‐19 under HG conditions using cultured human RE cells as the test system for experiments with recombinant protein, conditioned medium from ARPE‐19 and RNA interference (RNAi).Results:  The conditioned medium from ARPE‐19 cultured under HG conditions promoted tube formation of cultured human RE cells. GeneChip analysis showed that ANGPTL4 was one of the highest upregulated genes under HG conditions. In addition, recombinant ANGPTL4 promoted all of the elements of angiogenesis in human RE cells in vitro. The results of experiments using conditioned medium from ARPE‐19 combined with RNAi demonstrated that ANGPTL4 was a major angiogenic factor released from ARPE‐19 under HG conditions.Conclusions:  ANGPTL4 was induced by high glucose in RPE cells and exhibited potent angiogenic activity on RE cells. Our results are unique and may potentially add a new candidate to the long list of molecules involved in diabetic retinopathy.

Từ khóa


Tài liệu tham khảo

10.1056/NEJM199412013312203

10.2337/db05-1635

10.1373/49.1.32

10.1006/jmcc.2002.2021

10.1001/archopht.1986.01050150124042

10.1074/jbc.M109768200

10.1016/0014-4835(89)90092-4

10.1161/01.RES.0000250758.63358.91

Dhanabal M, 2002, Angioarrestin: an antiangiogenic protein with tumor‐inhibiting properties, Cancer Res, 62, 3834

Dunn KC, 1998, Use of ARPE‐19 cell line as a model of RPE polarity: basolateral secretion of FGF5, Invest Ophthalmol Vis Sci, 39, 2744

10.1017/S0007114507882961

Folkman J, 1986, How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture, Cancer Res, 46, 467

10.1016/j.ophtha.2005.10.030

10.1152/ajpendo.90345.2008

10.2353/ajpath.2010.100129

10.1016/j.clim.2004.12.002

10.2337/dc06-0556

Hewitt AT, 1997, Retina, 57

10.1182/blood-2011-01-328716

Ito Y, 2003, Inhibition of angiogenesis and vascular leakiness by angiopoietin‐related protein 4, Cancer Res, 63, 6651

10.1074/jbc.M004029200

Kim I, 2000, Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin‐related protein that prevents endothelial‐cell apoptosis, Biochem J, 346, 603, 10.1042/bj3460603

10.1210/en.2005-0476

10.1073/pnas.0501902102

10.1016/S0002-9440(10)64285-X

10.3390/ijms11010370

10.1167/iovs.07-0014

Nishimura W, 2002, Interaction of synaptic scaffolding molecule and Beta ‐catenin, J Neurosci, 22, 757, 10.1523/JNEUROSCI.22-03-00757.2002

10.1182/blood-2003-04-1272

10.1016/j.molmed.2005.08.002

10.1074/jbc.M111.220061

10.1111/j.1471-4159.2006.03885.x

10.1016/S0002-9440(10)65312-6

10.1006/bbrc.1996.0568

10.1073/pnas.90.4.1526

10.1016/0092-8674(88)90485-0

10.1016/j.ajo.2004.10.004

10.1056/NEJMoa041773

10.2337/diab.42.6.801

10.1016/j.bbrc.2006.07.032

10.1016/j.exer.2006.02.016

10.1128/MCB.20.14.5343-5349.2000

10.1016/j.exer.2004.11.015